NCT00704496View on ClinicalTrials.gov

The Effect of Pseudoephedrine on Rhinitis and Sleep

PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
RhinitisSleep
Interventions
DRUG

Pseudoephedrine

Pseudoephedrine is a 240 mg PO per day

Trial Locations (1)

17033

Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey

All Listed Sponsors
lead

Milton S. Hershey Medical Center

OTHER

NCT00704496 - The Effect of Pseudoephedrine on Rhinitis and Sleep | Biotech Hunter | Biotech Hunter